Dai, W.F.; Craig, E.; Fraser, B.; Chambers, A.; Mai, H.; Brown, M.B.; Earle, C.C.; Evans, W.K.; Geirnaert, M.; Taylor, M.;
et al. Building a National Reassessment Process for Oncology Drugs: Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration through a Simulated Reassessment Exercise. Curr. Oncol. 2021, 28, 4645-4654.
https://doi.org/10.3390/curroncol28060392
AMA Style
Dai WF, Craig E, Fraser B, Chambers A, Mai H, Brown MB, Earle CC, Evans WK, Geirnaert M, Taylor M,
et al. Building a National Reassessment Process for Oncology Drugs: Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration through a Simulated Reassessment Exercise. Current Oncology. 2021; 28(6):4645-4654.
https://doi.org/10.3390/curroncol28060392
Chicago/Turabian Style
Dai, Wei Fang, Erica Craig, Brent Fraser, Alex Chambers, Helen Mai, M. Bryson Brown, Craig C. Earle, William K. Evans, Marc Geirnaert, Marianne Taylor,
and et al. 2021. "Building a National Reassessment Process for Oncology Drugs: Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration through a Simulated Reassessment Exercise" Current Oncology 28, no. 6: 4645-4654.
https://doi.org/10.3390/curroncol28060392
APA Style
Dai, W. F., Craig, E., Fraser, B., Chambers, A., Mai, H., Brown, M. B., Earle, C. C., Evans, W. K., Geirnaert, M., Taylor, M., Trudeau, M., Sperber, D., Beca, J. M., Denburg, A., Mercer, R. E., Parmar, A., Tadrous, M., Takhar, P., Chan, K. K. W.,
& on behalf of the CanREValue Collaboration.
(2021). Building a National Reassessment Process for Oncology Drugs: Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration through a Simulated Reassessment Exercise. Current Oncology, 28(6), 4645-4654.
https://doi.org/10.3390/curroncol28060392
